Shots:

• Hologic to acquire Diagenode for ~$159M. The transaction will expand and diversifies Hologic’s diagnostic business across test menu- customer segments and geography
• The acquisition will strengthen Hologic’s molecular diagnostics business by expanding international its capabilities and allow it to offer a broader more differentiated test menu
• Diagenode and Hologic previously collaborated to develop Hologic’s Panther Fusion assays for detecting streptococcus and Bordetella

 ­ Ref: Businesswire | Image: Hologic